RxDoctor Payments Data

Kenneth Adelman, MD

Psychiatry · Watertown, MANPI 1497700694

Payments from drug & device makers

$812in general payments, 2019–2025

Across 51 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$168
  • Sunovion Pharmaceuticals Inc.$135
  • Neurocrine Biosciences, Inc.$121
  • AbbVie$84
  • Teva Pharmaceuticals USA, Inc.$60
  • Orexo US, Inc.$60
  • plus $184 from 6 others

What the payments were for

  • Food & beverage$76594%
  • Education$476%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$812 in reported general payments places this provider in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$75,911
Medicare patients
64
Services billed
798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole38$51,385
Aripiprazole87$17,241
VraylarCariprazine Hcl11$15,000
VyvanseLisdexamfetamine Dimesylate21$9,543
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine265$8,796
BelsomraSuvorexant13$8,718
Lisdexamfetamine Dimesylate25$7,306
Clonazepam523$5,040
Gabapentin254$4,252
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine64$3,798
Quetiapine Fumarate105$2,392
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$1,760
Lamotrigine91$1,594
Lorazepam180$1,574
Alprazolam163$1,558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$168$51,38538 claims
AbbVieVraylar$84$15,00011 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$43$9,54321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Watertown

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →